Search This Blog

Monday, November 16, 2026

Parkinson's Disease Linked to Agent Orange Exposure

 

  • Agent Orange is a defoliant widely used by the U.S. during the Vietnam War; components of the weedkiller are still used today.
  • In a study of 4.5 million veterans, those who directly handled Agent Orange were twice as likely to develop Parkinson's disease.
  • Exposure to Agent Orange also raised veterans' risk of synuclein-based neurodegenerative disorders by 57%.

Vietnam-era military veterans exposed to the weedkiller Agent Orange had a higher risk of developing Parkinson's disease and other neurodegenerative synucleinopathies, a study of more than 4 million Veterans Affairs (VA) health records showed.

Agent Orange exposure was associated with a 57% greater risk of developing a synuclein-based neurodegenerative disorder (HR 1.57, 95% CI 150-1.63), said Gregory Scott, MD, PhD, of the Oregon Health & Science University (OHSU) and the VA Portland Health Care System, and colleagues.

This included increased risks for Parkinson's disease (HR 1.44, 95% CI 1.37-1.52), rapid eye movement (REM) sleep behavior disorder (HR 1.78, 95% CI 1.68-1.89), and dementia with Lewy bodies (HR 1.66, 95% CI 1.32-2.09), the researchers reported in JAMA Neurology.

Veterans with direct occupational handling of Agent Orange were twice as likely to develop Parkinson's disease (HR 1.99, 95% CI 1.71-2.32) or REM sleep behavior disorder (HR 2.25, 95% CI 1.87-2.70) compared with those who were unexposed, Scott and co-authors added.

Clinicians and veterans have long suspected a link between Agent Orange and neurodegenerative diseases like Parkinson's, the researchers noted. The National Academies of Sciences, Engineering, and Medicine, which has evaluated other health effects linked with Agent Orange, has repeatedly called for assessments of Parkinson's risk.

"This is the first study in veterans to identify that increased risk of Parkinson's is associated with heavier exposure to Agent Orange," Scott said in a statement. "We're catching up with history in a way."

The VA findings also raise awareness about the risks of exposure to other chemical pesticides and herbicides, Scott observed. "I think this adds weight to the idea that we ought to get on top of this and not wait 50 years for the next herbicide to be linked to neurodegenerative disease," he said.

Agent Orange was a defoliant widely used by the U.S. during the Vietnam War to uncover the positions of North Vietnamese soldiers, noted Samuel Goldman, MD, MPH, of the University of California San Francisco, and colleagues.

"The weedkiller was a 50:50 mixture of the herbicides 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) along with small amounts of a potent carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a by-product of the manufacturing process," Goldman and co-authors wrote in an accompanying editorial.

Farmers, groundskeepers, and people who live near locations where herbicides are applied are currently exposed to these Agent Orange components, the editorialists pointed out.

"Although 2,4,5-T usage was phased out during the 1970s and banned in most countries by 1985, 2,4-D continues to be one of the most-used herbicides globally and is registered in over 90 countries. In the U.S., over 20 million kg of 2,4-D are applied annually for agricultural purposes, four times the amount of paraquat applied," they stated.

Today, 2,4-D is used on turf grass, highways, golf courses, gardens, and yards, the editorialists pointed out. Recent research showed that living within a mile of a golf course was associated with a 126% increased risk of Parkinson's disease, and other studies have found that groundskeepers and other greenspace workers have a higher risk of Parkinson's, Goldman and colleagues added.

The VA study followed 4,468,509 U.S. veterans with a mean age of 60.6 years from 1999 through 2022. Participants served during the Vietnam War era, from August 1964 to May 1975.

Of these, 1,035,210 veterans (23.2%) had self-reported Agent Orange exposure, and 7,600 (0.2%) had direct or occupational exposure. Direct or occupational exposure was defined by involvement in Operation Ranch Hand, Army Chemical Corps, or direct handling or spraying.

The analysis balanced birth year, age at the start of VA records, sex, race, ethnicity, and smoking history between exposed and unexposed groups, and adjusted findings for traumatic brain injury and frailty.

Agent Orange exposure and intensity were not directly measured in this study, Scott and colleagues acknowledged. "Although the exact number of veterans exposed to Agent Orange is unknown, over 8 million veterans are believed to have served in the Vietnam Era, with approximately one-third serving in the Vietnam theater and considered at high risk for Agent Orange exposure," they noted.

OHSU President Shereef Elnahal, MD, MBA, who previously served as the U.S. undersecretary of Veterans Affairs for health, noted that the PACT Act of 2022 extended healthcare benefits to military veterans exposed to toxic substances like Agent Orange, removing the burden of proof for veterans trying to access care. This study reinforces why the PACT Act was so important, he observed.

"This research offers critical insight for veterans who may have been diagnosed with Parkinson's even decades after their exposure to Agent Orange in Southeast Asia," Elnahal said in a statement. "Veterans who put themselves in harm's way deserve to know the truth no matter how long it takes."

Disclosures

The research was supported by the U.S. Department of Veterans Affairs, the John and Tami Marick Family Foundation, the Collins Medical 356 Trust Award, the OHSU MRF New Investigator Award, the Parkinson's Center of Oregon Pilot Award, the Department of Defense, the National Institute on Aging, and the Military Exposures Research Program.

Scott had no conflicts of interest. Co-authors reported relationships with the NIH, the Veterans Administration, the Department of Defense, and the Parkinson's Foundation.

Goldman had no conflicts of interest. One editorialist reported relationships with Advarra, Aspen Neuroscience, Bial Pharmaceuticals, Genentech, HanAll Biopharma, Mediflix, MedRhythms, Mitsubishi Tanabe Pharma America, Remepy, Sanofi, Synucure Therapeutics, Vima Therapeutics, VivoSense, Chorea Index, Atria Health and Research Institute, Health Mediflix, SemCap, Synapticure, the Edmond J. Safra Foundation, and the B. Thomas Golisano Foundation.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.